X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (288) 288
index medicus (246) 246
angiomyolipoma (228) 228
tuberous sclerosis (178) 178
female (172) 172
tuberous sclerosis complex (139) 139
adult (120) 120
male (104) 104
everolimus (99) 99
rapamycin (92) 92
lymphangioleiomyomatosis (91) 91
sirolimus (89) 89
sirolimus - therapeutic use (81) 81
tuberous sclerosis - complications (77) 77
middle aged (73) 73
tumors (73) 73
angiomyolipoma - drug therapy (70) 70
treatment outcome (70) 70
care and treatment (61) 61
urology & nephrology (58) 58
angiomyolipoma - pathology (57) 57
sporadic lymphangioleiomyomatosis (56) 56
oncology (54) 54
renal angiomyolipoma (54) 54
tuberous sclerosis - drug therapy (53) 53
kidney neoplasms - drug therapy (51) 51
kidney neoplasms - pathology (51) 51
antineoplastic agents - therapeutic use (49) 49
mtor (48) 48
mutation (47) 47
tuberous sclerosis - genetics (47) 47
cancer (44) 44
tor serine-threonine kinases - antagonists & inhibitors (43) 43
tumor suppressor proteins - genetics (43) 43
adolescent (42) 42
diagnosis (42) 42
mammalian target (42) 42
pediatrics (41) 41
pulmonary lymphangioleiomyomatosis (41) 41
research (41) 41
management (40) 40
aged (38) 38
sirolimus - analogs & derivatives (38) 38
tomography, x-ray computed (38) 38
congenital, hereditary, and neonatal diseases and abnormalities (37) 37
child (36) 36
immunosuppressive agents - therapeutic use (36) 36
kidneys (35) 35
tuberous sclerosis - pathology (35) 35
young adult (35) 35
medicine (34) 34
epilepsy (33) 33
angiomyolipoma - therapy (32) 32
therapy (32) 32
animals (31) 31
drug therapy (31) 31
efficacy (31) 31
health aspects (31) 31
kidney (31) 31
kidney neoplasms - therapy (31) 31
medicine & public health (31) 31
surgery (31) 31
lymphangioleiomyomatosis - drug therapy (30) 30
patients (30) 30
tsc2 (30) 30
complex (29) 29
everolimus - therapeutic use (29) 29
giant-cell astrocytomas (29) 29
magnetic resonance imaging (29) 29
multicenter (29) 29
nephrectomy (29) 29
angiomyolipoma - complications (28) 28
article (28) 28
abridged index medicus (27) 27
angiomyolipoma - surgery (27) 27
radiology, nuclear medicine & medical imaging (26) 26
safety (26) 26
tor protein (26) 26
analysis (25) 25
child, preschool (25) 25
kidney neoplasms - diagnostic imaging (25) 25
angiomyolipoma - diagnostic imaging (24) 24
kidney neoplasms - surgery (24) 24
medicine, general & internal (24) 24
mtor inhibitors (24) 24
neoplasms (24) 24
tor serine-threonine kinases - metabolism (24) 24
consensus conference (23) 23
kidney transplantation (23) 23
lymphangioleiomyomatosis - pathology (23) 23
angiomyolipoma - diagnosis (22) 22
angiomyolipoma - etiology (22) 22
kidney neoplasms - complications (22) 22
tsc2 protein (22) 22
angiomyolipoma - genetics (21) 21
diagnosis, differential (21) 21
multidisciplinary sciences (21) 21
pecoma (21) 21
respiratory system (21) 21
risk factors (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (363) 363
Chinese (2) 2
French (2) 2
German (2) 2
Japanese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 19, pp. 1801 - 1811
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 15, pp. 1426 - 1433
After a prolonged response, an anaplastic thyroid cancer developed resistance to mammalian target of rapamycin (mTOR) inhibition by somatic mutation of mTOR at... 
MEDICINE, GENERAL & INTERNAL | ACTIVATION | MTOR MUTATIONS | PROTEIN | LYMPHANGIOLEIOMYOMATOSIS | INHIBITION | TUBEROUS SCLEROSIS COMPLEX | ANGIOMYOLIPOMA | GENE-PRODUCTS | SENSITIVITY | SIROLIMUS | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Humans | Middle Aged | Thyroid Neoplasms - diagnostic imaging | Thyroid Carcinoma, Anaplastic | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasm Recurrence, Local - pathology | Radiography | Thyroid Neoplasms - therapy | Thyroid Neoplasms - genetics | Drug Resistance, Neoplasm - genetics | TOR Serine-Threonine Kinases - genetics | Neoplasm Recurrence, Local - diagnostic imaging | TOR Serine-Threonine Kinases - chemistry | Lymphatic Metastasis - pathology | Tumor Suppressor Proteins - genetics | Female | Protein Conformation | Mutation | Everolimus | Thyroid Neoplasms - pathology | Thyroid cancer | Research | Drug therapy | Patient outcomes | TOR protein | Tuberous sclerosis 2 protein | Nonsense mutation | Genomes | Metastasis | Drug resistance | Kinases | Cancer therapies | Metastases | Thyroid carcinoma | Proteins | Allosteric properties | Deoxyribonucleic acid--DNA | Crystal structure | Thyroid | Rapamycin | FDA approval | Radiation therapy | Patients | Studies | TSC2 protein | Chemotherapy | Womens health | Biopsy | Tumors
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2011, Volume 154, Issue 12, pp. 797 - 805
Background: Lymphangioleiomyomatosis (LAM) is a disorder that affects women and is characterized by cystic lung destruction, chylous effusions,... 
RAPAMYCIN | CHYLOTHORAX | WOMEN | MEDICINE, GENERAL & INTERNAL | TUBEROUS SCLEROSIS COMPLEX | PULMONARY LYMPHANGIOLEIOMYOMATOSIS | IFN-GAMMA | GENE-PRODUCTS | DISEASE | LAM | MOUSE MODELS | Lung Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Lymphangioleiomyomatosis - physiopathology | Middle Aged | Pleural Effusion - physiopathology | Antibiotics, Antineoplastic - adverse effects | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lymphangiomyoma - diagnostic imaging | Lung Neoplasms - physiopathology | Angiomyolipoma - drug therapy | Antibiotics, Antineoplastic - blood | Angiomyolipoma - physiopathology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Immunosuppressive Agents - blood | Adult | Female | Sirolimus - adverse effects | Chyle - secretion | Sirolimus - therapeutic use | Angiomyolipoma - diagnostic imaging | Lung - physiopathology | Lymphangioleiomyomatosis - drug therapy | Sirolimus - blood | Lymphangiomyoma - physiopathology | Lymphangiomyoma - drug therapy | Antibiotics, Antineoplastic - therapeutic use | Observation | Immunosuppressive Agents - adverse effects | Lung Neoplasms - diagnostic imaging | Cell Proliferation - drug effects | Lymphangioleiomyomatosis - diagnostic imaging | Respiratory Function Tests | Muscle, Smooth - pathology | Leiomyoma | Tuberous sclerosis | Physiological aspects | Research | Lungs | Drug therapy
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2008, Volume 358, Issue 2, pp. 140 - 151
Journal Article